Qube Research & Technologies LTD Argenx Se Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $3.04 Million - $3.85 Million	-8,532 Reduced 68.88%	3,855 $1.66 Million
Q1 2024 May 14, 2024	BUY	$356.95 - $413.29 $1.57 Million - $1.82 Million	4,397 Added 55.03%	12,387 $4.88 Million
Q4 2023 Feb 13, 2024	SELL	$338.91 - $506.01 $22 Million - $32.9 Million	-64,954 Reduced 89.05%	7,990 $3.04 Million
Q3 2023 Nov 13, 2023	BUY	$369.35 - $548.43 $13.7 Million - $20.4 Million	37,170 Added 103.9%	72,944 $35.9 Million
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $8.19 Million - $9.61 Million	22,742 Added 174.51%	35,774 $13.9 Million
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $8.22 Million - $9.92 Million	-24,587 Reduced 65.36%	13,032 $4.86 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $8.29 Million - $9.74 Million	24,217 Added 180.7%	37,619 $14.3 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $4.6 Million - $5.3 Million	13,402 New	13,402 $4.73 Million
Q4 2021 Feb 01, 2022	SELL	$272.01 - $353.03 $3.44 Million - $4.47 Million	-12,657 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $1.24 Million - $1.48 Million	4,218 Added 49.98%	12,657 $3.82 Million
Q2 2021 Aug 13, 2021	SELL	$257.11 - $319.92 $1.09 Million - $1.35 Million	-4,228 Reduced 33.38%	8,439 $2.54 Million
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $1.64 Million - $2.33 Million	6,118 Added 93.42%	12,667 $3.49 Million
Q4 2020 Feb 16, 2021	BUY	$248.13 - $308.36 $1.63 Million - $2.02 Million	6,549 New	6,549 $1.93 Million
Q3 2020 Nov 12, 2020	SELL	$215.51 - $272.51 $3.46 Million - $4.38 Million	-16,067 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $2.05 Million - $3.74 Million	16,067 New	16,067 $3.62 Million
Q1 2020 May 15, 2020	SELL	$108.83 - $165.23 $651,674 - $989,397	-5,988 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$106.59 - $164.21 $638,260 - $983,289	5,988 New	5,988 $961,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.66 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.21 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.56 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.07 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$778 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account